1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mice Models
1.2.3 Rat Models
1.3 Market by Application
1.3.1 Global Patient Derived Xenograft/PDX Models Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pre-clinical Drug Development and Basic Cancer Research
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Derived Xenograft/PDX Models Market Perspective (2016-2027)
2.2 Patient Derived Xenograft/PDX Models Growth Trends by Regions
2.2.1 Patient Derived Xenograft/PDX Models Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Patient Derived Xenograft/PDX Models Historic Market Share by Regions (2016-2021)
2.2.3 Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027)
2.3 Patient Derived Xenograft/PDX Models Industry Dynamic
2.3.1 Patient Derived Xenograft/PDX Models Market Trends
2.3.2 Patient Derived Xenograft/PDX Models Market Drivers
2.3.3 Patient Derived Xenograft/PDX Models Market Challenges
2.3.4 Patient Derived Xenograft/PDX Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue
3.1.1 Global Top Patient Derived Xenograft/PDX Models Players by Revenue (2016-2021)
3.1.2 Global Patient Derived Xenograft/PDX Models Revenue Market Share by Players (2016-2021)
3.2 Global Patient Derived Xenograft/PDX Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Patient Derived Xenograft/PDX Models Revenue
3.4 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio
3.4.1 Global Patient Derived Xenograft/PDX Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Derived Xenograft/PDX Models Revenue in 2020
3.5 Patient Derived Xenograft/PDX Models Key Players Head office and Area Served
3.6 Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
3.7 Date of Enter into Patient Derived Xenograft/PDX Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Derived Xenograft/PDX Models Breakdown Data by Type
4.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Type (2016-2021)
4.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027)
5 Patient Derived Xenograft/PDX Models Breakdown Data by Application
5.1 Global Patient Derived Xenograft/PDX Models Historic Market Size by Application (2016-2021)
5.2 Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
6.2 North America Patient Derived Xenograft/PDX Models Market Size by Type
6.2.1 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
6.2.2 North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
6.2.3 North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
6.3 North America Patient Derived Xenograft/PDX Models Market Size by Application
6.3.1 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
6.3.2 North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
6.3.3 North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
6.4 North America Patient Derived Xenograft/PDX Models Market Size by Country
6.4.1 North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
6.4.2 North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Patient Derived Xenograft/PDX Models Market Size (2016-2027)
7.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type
7.2.1 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
7.2.2 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
7.2.3 Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
7.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application
7.3.1 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
7.3.2 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
7.3.3 Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
7.4 Europe Patient Derived Xenograft/PDX Models Market Size by Country
7.4.1 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
7.4.2 Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size (2016-2027)
8.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type
8.2.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
8.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application
8.3.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
8.4 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region
8.4.1 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Patient Derived Xenograft/PDX Models Market Size (2016-2027)
9.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type
9.2.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
9.2.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
9.2.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
9.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application
9.3.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
9.3.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
9.3.3 Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
9.4 Latin America Patient Derived Xenograft/PDX Models Market Size by Country
9.4.1 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
9.4.2 Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size (2016-2027)
10.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type
10.2.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2027)
10.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application
10.3.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2027)
10.4 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country
10.4.1 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient Derived Xenograft/PDX Models Introduction
11.1.4 Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.1.5 Crown Bioscience Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Details
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory Patient Derived Xenograft/PDX Models Introduction
11.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.2.5 The Jackson Laboratory Recent Development
11.3 Champions Oncology
11.3.1 Champions Oncology Company Details
11.3.2 Champions Oncology Business Overview
11.3.3 Champions Oncology Patient Derived Xenograft/PDX Models Introduction
11.3.4 Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.3.5 Champions Oncology Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Details
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Patient Derived Xenograft/PDX Models Introduction
11.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.4.5 Charles River Laboratories Recent Development
11.5 WuXi Apptec
11.5.1 WuXi Apptec Company Details
11.5.2 WuXi Apptec Business Overview
11.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Introduction
11.5.4 WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.5.5 WuXi Apptec Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Details
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient Derived Xenograft/PDX Models Introduction
11.6.4 Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.6.5 Oncodesign Recent Development
11.7 Horizon Discovery
11.7.1 Horizon Discovery Company Details
11.7.2 Horizon Discovery Business Overview
11.7.3 Horizon Discovery Patient Derived Xenograft/PDX Models Introduction
11.7.4 Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.7.5 Horizon Discovery Recent Development
11.8 Pharmatest Services
11.8.1 Pharmatest Services Company Details
11.8.2 Pharmatest Services Business Overview
11.8.3 Pharmatest Services Patient Derived Xenograft/PDX Models Introduction
11.8.4 Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.8.5 Pharmatest Services Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Details
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Introduction
11.9.4 Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.9.5 Hera Biolabs Recent Development
11.10 EPO Berlin-Buch
11.10.1 EPO Berlin-Buch Company Details
11.10.2 EPO Berlin-Buch Business Overview
11.10.3 EPO Berlin-Buch Patient Derived Xenograft/PDX Models Introduction
11.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.10.5 EPO Berlin-Buch Recent Development
11.11 Xentech
11.11.1 Xentech Company Details
11.11.2 Xentech Business Overview
11.11.3 Xentech Patient Derived Xenograft/PDX Models Introduction
11.11.4 Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.11.5 Xentech Recent Development
11.12 Urolead
11.12.1 Urolead Company Details
11.12.2 Urolead Business Overview
11.12.3 Urolead Patient Derived Xenograft/PDX Models Introduction
11.12.4 Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021)
11.12.5 Urolead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Patient Derived Xenograft/PDX Models Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mice Models
Table 3. Key Players of Rat Models
Table 4. Global Patient Derived Xenograft/PDX Models Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Patient Derived Xenograft/PDX Models Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Patient Derived Xenograft/PDX Models Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2016-2021)
Table 8. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
Table 10. Patient Derived Xenograft/PDX Models Market Trends
Table 11. Patient Derived Xenograft/PDX Models Market Drivers
Table 12. Patient Derived Xenograft/PDX Models Market Challenges
Table 13. Patient Derived Xenograft/PDX Models Market Restraints
Table 14. Global Patient Derived Xenograft/PDX Models Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Patient Derived Xenograft/PDX Models Market Share by Players (2016-2021)
Table 16. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020)
Table 17. Ranking of Global Top Patient Derived Xenograft/PDX Models Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Patient Derived Xenograft/PDX Models Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Patient Derived Xenograft/PDX Models Product Solution and Service
Table 21. Date of Enter into Patient Derived Xenograft/PDX Models Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
Table 25. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Patient Derived Xenograft/PDX Models Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2016-2021)
Table 29. Global Patient Derived Xenograft/PDX Models Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size by Country (2022-2027) & (US$ Million)
Table 61. Crown Bioscience Company Details
Table 62. Crown Bioscience Business Overview
Table 63. Crown Bioscience Patient Derived Xenograft/PDX Models Product
Table 64. Crown Bioscience Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 65. Crown Bioscience Recent Development
Table 66. The Jackson Laboratory Company Details
Table 67. The Jackson Laboratory Business Overview
Table 68. The Jackson Laboratory Patient Derived Xenograft/PDX Models Product
Table 69. The Jackson Laboratory Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 70. The Jackson Laboratory Recent Development
Table 71. Champions Oncology Company Details
Table 72. Champions Oncology Business Overview
Table 73. Champions Oncology Patient Derived Xenograft/PDX Models Product
Table 74. Champions Oncology Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 75. Champions Oncology Recent Development
Table 76. Charles River Laboratories Company Details
Table 77. Charles River Laboratories Business Overview
Table 78. Charles River Laboratories Patient Derived Xenograft/PDX Models Product
Table 79. Charles River Laboratories Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 80. Charles River Laboratories Recent Development
Table 81. WuXi Apptec Company Details
Table 82. WuXi Apptec Business Overview
Table 83. WuXi Apptec Patient Derived Xenograft/PDX Models Product
Table 84. WuXi Apptec Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 85. WuXi Apptec Recent Development
Table 86. Oncodesign Company Details
Table 87. Oncodesign Business Overview
Table 88. Oncodesign Patient Derived Xenograft/PDX Models Product
Table 89. Oncodesign Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 90. Oncodesign Recent Development
Table 91. Horizon Discovery Company Details
Table 92. Horizon Discovery Business Overview
Table 93. Horizon Discovery Patient Derived Xenograft/PDX Models Product
Table 94. Horizon Discovery Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 95. Horizon Discovery Recent Development
Table 96. Pharmatest Services Company Details
Table 97. Pharmatest Services Business Overview
Table 98. Pharmatest Services Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 99. Pharmatest Services Recent Development
Table 100. Hera Biolabs Company Details
Table 101. Hera Biolabs Business Overview
Table 102. Hera Biolabs Patient Derived Xenograft/PDX Models Product
Table 103. Hera Biolabs Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 104. Hera Biolabs Recent Development
Table 105. EPO Berlin-Buch Company Details
Table 106. EPO Berlin-Buch Business Overview
Table 107. EPO Berlin-Buch Patient Derived Xenograft/PDX Models Product
Table 108. EPO Berlin-Buch Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 109. EPO Berlin-Buch Recent Development
Table 110. Xentech Company Details
Table 111. Xentech Business Overview
Table 112. Xentech Patient Derived Xenograft/PDX Models Product
Table 113. Xentech Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 114. Xentech Recent Development
Table 115. Urolead Company Details
Table 116. Urolead Business Overview
Table 117. Urolead Patient Derived Xenograft/PDX Models Product
Table 118. Urolead Revenue in Patient Derived Xenograft/PDX Models Business (2016-2021) & (US$ Million)
Table 119. Urolead Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Patient Derived Xenograft/PDX Models Market Share by Type: 2020 VS 2027
Figure 2. Mice Models Features
Figure 3. Rat Models Features
Figure 4. Global Patient Derived Xenograft/PDX Models Market Share by Application: 2020 VS 2027
Figure 5. Pre-clinical Drug Development and Basic Cancer Research Case Studies
Figure 6. Biomarker Analysis Case Studies
Figure 7. Patient Derived Xenograft/PDX Models Report Years Considered
Figure 8. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Patient Derived Xenograft/PDX Models Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Patient Derived Xenograft/PDX Models Market Share by Regions: 2020 VS 2027
Figure 11. Global Patient Derived Xenograft/PDX Models Market Share by Regions (2022-2027)
Figure 12. Global Patient Derived Xenograft/PDX Models Market Share by Players in 2020
Figure 13. Global Top Patient Derived Xenograft/PDX Models Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patient Derived Xenograft/PDX Models as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Patient Derived Xenograft/PDX Models Revenue in 2020
Figure 15. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2016-2021)
Figure 16. Global Patient Derived Xenograft/PDX Models Revenue Market Share by Type (2022-2027)
Figure 17. North America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 19. North America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 20. North America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 21. United States Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 25. Europe Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 26. Europe Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 27. Germany Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Patient Derived Xenograft/PDX Models Market Share by Region (2016-2027)
Figure 37. China Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 45. Latin America Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 46. Latin America Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 47. Mexico Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Patient Derived Xenograft/PDX Models Market Share by Country (2016-2027)
Figure 53. Turkey Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Patient Derived Xenograft/PDX Models Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Crown Bioscience Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 57. The Jackson Laboratory Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 58. Champions Oncology Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 59. Charles River Laboratories Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 60. WuXi Apptec Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 61. Oncodesign Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 62. Horizon Discovery Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 63. Pharmatest Services Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 64. Hera Biolabs Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 65. EPO Berlin-Buch Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 66. Xentech Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 67. Urolead Revenue Growth Rate in Patient Derived Xenograft/PDX Models Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Crown Bioscience The Jackson Laboratory Champions Oncology Charles River Laboratories WuXi Apptec Oncodesign Horizon Discovery Pharmatest Services Hera Biolabs EPO Berlin-Buch Xentech Urolead